[Treatment of ARDS--present status and an outlook for the future].
Amaha
K
K
D011464:Epoprostenol / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D009569:Nitric Oxide / Q000627:therapeutic use; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012015:Reference Standards; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*
D011663:Pulmonary Surfactants; D009569:Nitric Oxide; D011464:Epoprostenol